NEW YORK (360Dx) – Swiss diagnostics firm ProteoMedix said today it has raised CHF 5.2 million ($5.3 million) in equity funding from existing investors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.